The Food and Drug Administration has granted Fast Track designation to emrusolmin (TEV-56286) for the treatment of multiple system atrophy.

A poster, entitled, “ATH434 Slowed Disease Progression in a Phase 2 Study in Multiple System Atrophy,” was presented by Daniel Claassen, M.D., M.S., Professor of Neurology at Vanderbilt University ...

In 2025, around 36,110 new cases will be diagnosed, and about 12,030 US adults will die of the disease, according to the ...

Multiple myeloma is preceded by an asymptomatic expansion of clonal plasma cells that is detected clinically and described as smoldering multiple myeloma. Studies have identified a fraction of cases ...

An experimental transcatheter shunt system that moves blood from the left atrium to the right atrium in patients with heart failure provided even greater benefit at 2 years than in the first year, ...